Progesterone for the Prevention of Preterm Birth Paul Meis MD.
Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice...
Transcript of Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice...
![Page 1: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/1.jpg)
Amy Murtha, MD
Associate Professor
Vice Chair for Research
Department of Ob/Gyn
Progesterone for the
Prevention of Preterm
Birth
![Page 2: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/2.jpg)
All Rights Reserved, Duke Medicine 2007
![Page 3: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/3.jpg)
All Rights Reserved, Duke Medicine 2007
Objectives
• Scope of the problem
• Role of progesterone in pregnancy
• Progesterone for preterm birth
prevention in different populations
• Controversies in the US
![Page 4: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/4.jpg)
All Rights Reserved, Duke Medicine 2007
Trends in Preterm Birth in the US
14
12
10
8
6
4
2
0
Perc
en
t
1990 1992 1994 1996 1998 2000 2002 2004 2006 2008 Year
Late preterm (34 - 36 weeks)
Early preterm (< 34 weeks)
Preterm (< 37 weeks)
Adapted from Source: CDC/NCHS, National Vital Statistics System.
11
![Page 5: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/5.jpg)
All Rights Reserved, Duke Medicine 2007
Preterm Birth
Preterm labor 45%
Indicated 30%
PPROM 25%
JM Moutquin – BJOG, 2003.
![Page 6: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/6.jpg)
All Rights Reserved, Duke Medicine 2007
World View: Land Area
www.World Mapper.org
![Page 7: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/7.jpg)
All Rights Reserved, Duke Medicine 2007
World View: Low Birth Weight Related Deaths
(<2500gms)
www.World Mapper.org;
Beck, Bull 31 World Health Organ 2010.
12.9 million births
preterm
10.9 million preterm
births in Africa & Asia
BUT.. Equal Preterm
Birth RATES between
North America and
Africa
![Page 8: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/8.jpg)
All Rights Reserved, Duke Medicine 2007
Ranking by Infant Mortality: US ranks 48th
https://www.cia.gov/library/publications/the-world-factbook/rankorder/2091rank.html
6.2 6.1
6.1 5.6
5 4.9 4.9
4.8 4.7
4.6 4.6 4.6
4.3 4.3
4.2 4.2
4.1 4.1
3.9 3.5
3.4 3.4 3.4
3.3 3.2
2.9 2.8
2.7 2.5
2.3 1.8
0 1 2 3 4 5 6 7 8
BelarusCroatia
United StatesE. U.
GreeceCanada
CubaNew Zealand
PortugalU.K.
AustraliaNetherlands
BelgiumAustria
DenmarkS. Korea
IsraelSwitzerland
IrelandGermany
FinlandSpain
ItalyFranceIceland
Hong KongJapan
SwedenBermuda
SingaporeMonaco
Rate per 1,000 live births
![Page 9: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/9.jpg)
All Rights Reserved, Duke Medicine 2007
Mathews TJ, MacDorman MF. Natl Vital Stat Rep. 2006;54(16):1-29.
Figure adapted with permission from Mercer BM. Obstet Gynecol. 2003;101(1):178-193.
Morbidity and Mortality of Preterm Birth as a
Function of Gestational Age
Healt
h a
nd
su
rviv
al
ou
tco
mes (
%)
Survival
RDS
Sepsis
IVH
NEC
0
20
40
60
80
100
Gestational age at birth (wks)
24 26 28 30 32 34 36
![Page 10: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/10.jpg)
All Rights Reserved, Duke Medicine 2007
Risk factors for preterm birth
Medical risk factors: • PROM • Infections (UTI, BV, STD) • High blood pressure • Diabetes • Clotting disorders (thrombophilia) • Maternal weight (underweight or
obesity) • Short time period between
pregnancies • Certain birth defects • Vaginal bleeding
Lifestyle risk factors: • Late or no prenatal care • Smoking • Drinking alcohol • Using illegal drugs • Domestic violence • Lack of social support • High levels of stress • Long working hours • Low income
• Previous preterm birth
• Multiple gestation
• Uterine/cervical anomalies
• Decreased cervical length
• African American race
• Age (<17, >35)
![Page 11: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/11.jpg)
All Rights Reserved, Duke Medicine 2007
PRIOR PRETERM BIRTH
Risk Factor
![Page 12: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/12.jpg)
All Rights Reserved, Duke Medicine 2007
Risk of recurrent preterm birth
First birth Second birth Subsequent preterm
birth (%)
Not preterm 4.4
Preterm 17.2
Not preterm Not preterm 2.6
Preterm Not preterm 5.7
Not preterm Preterm 11.1
Preterm Preterm 28.4
From Bakketeig LS et al,: Epigemiology of preterm birth: Results from a longitudinal study of births
in Norway. In Elder MG: Preterm Labor. London, Butterworths, 1981, p17.
![Page 13: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/13.jpg)
All Rights Reserved, Duke Medicine 2007
PROGESTERONE
![Page 14: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/14.jpg)
All Rights Reserved, Duke Medicine 2007
Progesterone
• Small hydrophobic steroid hormone
• Produced by ovaries (corpus luteum), adrenals,
placenta
• Diffuses freely through the plasma membrane of all
cells
• In target cells
• Binds to progesterone receptor
• Moves to nucleus
• Binds to a progesterone response element
• Transcription factor mRNA protein
![Page 15: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/15.jpg)
All Rights Reserved, Duke Medicine 2007
How does progesterone work to prevent
preterm birth?
1. Maintenance of uterine quiescence
2. Anti-inflammatory/immunosuppression
3. Cervical stroma
4. Autocrine/paracrine
![Page 16: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/16.jpg)
All Rights Reserved, Duke Medicine 2007
Labor and Progesterone’s Role
• Change in contractility from uncoordinated
contractures to coordinated contractions
– Results in increase intrauterine pressure
• Labor requires formation of Gap junctions and
expression of gap junction protein connexin 43
• Progesterone prevents formation of gap junctions
and expression of connexin 43
![Page 17: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/17.jpg)
All Rights Reserved, Duke Medicine 2007
ANTI-INFLAMMATORY &
IMMUNOSUPPRESSION
![Page 18: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/18.jpg)
All Rights Reserved, Duke Medicine 2007
Inflammation & Preterm Birth
PPROM &
PTL
Prostaglandins & MMPs
Proinflammatory
cytokines
(IL1β, IL6, IL8, TNFα)
Myometrium
Fetal membranes
Contractions Apoptosis
![Page 19: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/19.jpg)
All Rights Reserved, Duke Medicine 2007
Progesterone and Inflammation
• Progesterone, 17P, & MPA reduce TNF- α
induced caspase-3 activity (Luo et al, Reprod
Sciences, April 2010)
• Progesterone inhibits NFkβ induced
activation of COX2 induced uterine
contractility (Condon, Proc Natl Acad Sci USA, 2003)
• Progesterone protects chorion cells from
oxidative stress induced apoptotic cell death (Murtha, SMFM 2012)
![Page 20: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/20.jpg)
All Rights Reserved, Duke Medicine 2007
Progesterone Reduces TNF Induced
MMP9 Activity N
orm
alized
den
sit
y
of
MM
P 9
Choi,SJ; Annual Meeting for SMFM 2012
P=0.02
P=0.04
![Page 21: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/21.jpg)
All Rights Reserved, Duke Medicine 2007
ROLE IN CERVICAL
REMODELING
![Page 22: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/22.jpg)
All Rights Reserved, Duke Medicine 2007
Cervical Changes Preceding Labor
• Extracellular matrix
• Cervical ripening is result of
– decreased collagen content
– increased collagen solubility
– increased collagenolytic activity
![Page 23: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/23.jpg)
All Rights Reserved, Duke Medicine 2007
Cervical Changes Preceding Labor
• Influx of inflammatory cells into the
cervix
– Cytokines/prostaglandins affect
extracellular matrix metabolism
• PTB often preceded by cervical ripening
over weeks
![Page 24: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/24.jpg)
All Rights Reserved, Duke Medicine 2007
Progesterone’s action on the cervix
• Reduction in mediators of inflammation
and tissue destruction
– IL-1, IL-8, iNOS, COX-2
• Block of 17-β-estradiol induced collagen
degradation
![Page 25: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/25.jpg)
All Rights Reserved, Duke Medicine 2007
Progesterone for preterm birth prevention
• Singleton with prior PTB
• Multiples gestation
• Cervical length
• Vaginal progesterone
• 17P
![Page 26: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/26.jpg)
All Rights Reserved, Duke Medicine 2007
Singleton with history of PTB
![Page 27: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/27.jpg)
All Rights Reserved, Duke Medicine 2007
Singleton with history of PTB
![Page 28: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/28.jpg)
All Rights Reserved, Duke Medicine 2007
Singleton with history of PTB
![Page 29: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/29.jpg)
All Rights Reserved, Duke Medicine 2007
Effectiveness of Progesterone in women
with prior PTB
• 5-6 women with a previous sPTB would need to be
treated to prevent one birth <37 weeks
• 12 women with a previous sPTB birth would need to
be treated to prevent one birth <32 weeks
Meis et al, N Engl J Med 2003
![Page 30: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/30.jpg)
All Rights Reserved, Duke Medicine 2007
SHORTENED CERVIX
![Page 31: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/31.jpg)
All Rights Reserved, Duke Medicine 2007
Shortened cervix
Canal
Length
Funnel
Width
T Y
U V Zilianti M, et al: JUM 1995
Mechanism of Effacement:
Functional
Cervical
length
![Page 32: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/32.jpg)
All Rights Reserved, Duke Medicine 2007
Iams et al, NEJM 1996
Relative Risk of SPTD < 35 wks by % of
cervical length at 24 wks
Rela
tive
ris
k o
f
pre
matu
re d
eli
ve
ry
Nu
mb
er
of
wo
me
n
0
200
400
600
800
0
2
4
6
8
10
12
14
0 1.2 2.4 3.6 4.8 6.0
Length of cervix (cm)
Percentile
1 5 75 50 25 10
Relative
risk
No. of women
![Page 33: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/33.jpg)
All Rights Reserved, Duke Medicine 2007
ECM
Degradation
Short
Cervix
Pre-term Birth
Progesterone
Uterine
Contractility
Inflammation
Progesterone
Progesterone
![Page 34: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/34.jpg)
All Rights Reserved, Duke Medicine 2007
Short cervix
Fonseca, NEJM, 2007
![Page 35: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/35.jpg)
All Rights Reserved, Duke Medicine 2007
Short cervix
Fonseca, NEJM, 2007
Hassan, Ultrasound Obstet Gynecol, 2011
![Page 36: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/36.jpg)
All Rights Reserved, Duke Medicine 2007
Short Cervix Meta-analysis
• Meta-analysis of individual patient data from five
placebo-controlled trials
• Progesterone supplementation for short cervix
– 30 to 50 percent reduction in preterm birth <28,
<33, and <35 weeks
• 40 percent reduction in neonatal morbidity and
mortality
• Similar effects at 90, 100 and 200 mg daily and for
women with and without a history of prior preterm
birth
Romero et al, 2012
![Page 37: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/37.jpg)
All Rights Reserved, Duke Medicine 2007
Multiple gestation
![Page 38: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/38.jpg)
All Rights Reserved, Duke Medicine 2007
Multiple gestation- TWINS
Briery Twins
N=30
PTB < 35
wk
17-OHP
[20-30 until 34 wk]
2.24
[0.8-6.3]
![Page 39: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/39.jpg)
All Rights Reserved, Duke Medicine 2007
Multiple gestation- TWINS
Briery Twins
N=30
PTB < 35
wk
17-OHP
[20-30 until 34 wk]
2.24
[0.8-6.3]
Rouse Twins
N=661
Delivery
or death
< 35wk
17-OHP
[16-20 until 34 wk]
1.1
[0.09-1.3]
![Page 40: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/40.jpg)
All Rights Reserved, Duke Medicine 2007
Multiple gestation- TWINS
Briery Twins
N=30
PTB < 35
wk
17-OHP
[20-30 until 34 wk]
2.24
[0.8-6.3]
Rouse Twins
N=661
Delivery
or death
< 35wk
17-OHP
[16-20 until 34 wk]
1.1
[0.09-1.3]
Norman Twins
N=500
PTB or
death
<34 wk
Vaginal
progesterone gel
1.27
[0.91-1.78}
![Page 41: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/41.jpg)
All Rights Reserved, Duke Medicine 2007
Multiple gestation- TRIPLETS
Caritis Triplets
N=134
Delivery or
death
< 35wk
17-OHP
[16-20 until 35 wk]
1.0
[0.9-1.1]
![Page 42: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/42.jpg)
All Rights Reserved, Duke Medicine 2007
Multiple gestation- TRIPLETS
Caritis Triplets
N=134
Delivery or
death
< 35wk
17-OHP
[16-20 until 35 wk]
1.0
[0.9-1.1]
Combs Triplets
N=81
Composite
neonatal
morbidity
17-OHP
[16-22 until 34 wk]
0.9
[0.65-1.27]
![Page 43: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/43.jpg)
All Rights Reserved, Duke Medicine 2007
ADMINISTRATION OF
PROGESTERONE
• Formulations
• Timing of initiation & cessation
• Dose
• Frequency of use
![Page 44: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/44.jpg)
All Rights Reserved, Duke Medicine 2007
Formulations
• Oral micronized
• Intramuscular
– Compounded
– Makena
• Vaginal
– Crinone
– Compounded
Which one to use???
• Either IM or vaginal
depending on indication
![Page 45: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/45.jpg)
All Rights Reserved, Duke Medicine 2007
Dose
• What dose of progesterone should I use?
– IM: 250 mg weekly of 17-hydroxyprogesterone
caproate
– Intravaginal: unclear
• Compounded: 100-200 mg micronized progesterone
• Crinone 8% gel (90mg)
![Page 46: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/46.jpg)
All Rights Reserved, Duke Medicine 2007
Summary of recommendations
• Women with history of prior spontaneous PTB
between 20/0 and 36/6 SHOULD BE
OFFERED progesterone therapy
• Women with short (≤25mm) cervix SHOULD
BE OFFERED vaginal progesterone
• There are NO DATA to support use of
progesterone in women multiple gestation or
preterm labor
![Page 47: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/47.jpg)
All Rights Reserved, Duke Medicine 2007
LBW/Prematurity: Research Needs
Prior spontaneous PTD
• Only one risk factor
• Small % of all PTD
Spontaneous Indicated
PPROM
Major initiatives into:
-Understanding the cause(s)
-Methods of prevention and treatment in pregnant women
-Optimal management/treatment of neonates
![Page 48: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/48.jpg)
All Rights Reserved, Duke Medicine 2007
CONTROVERSIES IN THE US
![Page 49: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/49.jpg)
All Rights Reserved, Duke Medicine 2007
Progesterone and the US FDA- 17-P
• 17-P was initially denied FDA approval
– Insufficient evidence that it reduces preterm birth
<37 weeks
– Concern over pregnancy loss <20 weeks
• In 2011 FDA gives provisional approval for 17-P to be
marketed as Makena
– Company must complete new randomized trial to
answer
• Safety concerns
• Efficacy at <37 weeks
![Page 50: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/50.jpg)
All Rights Reserved, Duke Medicine 2007
Progesterone and the US FDA- 17-P
• TherRx begins marketing Makena at inflated
cost
• FDA decides to let compounding pharmacies
continue to make 17-P at a reduce cost
– First time FDA has approved a drug and
allowed compounding pharmacies continue
• Controversy continues over quality and
potency of compounded 17-P
![Page 51: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/51.jpg)
All Rights Reserved, Duke Medicine 2007
Progesterone and the US FDA- Crinone
• Crinone gel is micronized progesterone
used in the Hassan trial
• Marketed by Columbia Laboratories and
now moved to Watson Pharmaceuticals
• Columbia applied for FDA approval of
Crinone 8% gel for the prevention of
preterm birth in setting of short cervix
![Page 52: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/52.jpg)
All Rights Reserved, Duke Medicine 2007
Progesterone and the US FDA- Crinone
• 2012 FDA Special Advisory committee
recommended that FDA not approve Crinone
• Hassan trial did not meet the targeted P value
of .01
• Sub-analysis suggested that Crinone was not
effective in US population (P=0.2)
• Main Problem- in US without FDA approval
most insurance carriers will not pay for
vaginal progesterone
![Page 53: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/53.jpg)
All Rights Reserved, Duke Medicine 2007
AMERICAN COLLEGE OF
OBSTETRICS AND
GYNECOLOGY (ACOG)
![Page 54: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/54.jpg)
All Rights Reserved, Duke Medicine 2007
American College of Obstetrics and
Gynecology (ACOG)
• ACOG recommends screening by
trans-abdominal ultrasound
• A short cervix (<25 mm long) during
pregnancy may help predict the risk of
having a spontaneous preterm birth
![Page 55: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/55.jpg)
All Rights Reserved, Duke Medicine 2007
American College of Obstetrics and
Gynecology (ACOG)
• Transvaginal ultrasound screening for cervical length
should reserved for pregnant women with a prior
preterm birth carrying a single fetus
• Pregnant women with a prior preterm birth should be
offered progesterone (17-P) starting at 16 weeks
• Vaginal progesterone in setting of incidental short
cervix
• No effective treatments to prevent preterm birth for
women with a short cervix who are carrying multiple
fetuses
![Page 56: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/56.jpg)
All Rights Reserved, Duke Medicine 2007
![Page 57: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/57.jpg)
All Rights Reserved, Duke Medicine 2007
SUMMARY AND RECOMMENDATIONS
• For women with a prior spontaneous preterm birth,
intramuscular injections of 17-P (250 mg)rather than
vaginal progesterone
• For women with midtrimester cervical shortening
(defined as ≤20 mm before 24 weeks) and no prior
spontaneous preterm birth vaginal progesterone
treatment
– Options include a vaginal suppository (100 or 200
mg), gel (90 mg), or tablet (100 mg micronized
progesterone)
![Page 58: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/58.jpg)
All Rights Reserved, Duke Medicine 2007
![Page 59: Progesterone for the Prevention of Preterm · PDF fileAmy Murtha, MD Associate Professor Vice Chair for Research Department of Ob/Gyn Progesterone for the Prevention of Preterm Birth](https://reader034.fdocuments.net/reader034/viewer/2022042600/5ab1c8e77f8b9aea528cdd8b/html5/thumbnails/59.jpg)
Questions
Amy Murtha, MD
Associate Professor
Vice Chair for Research
Department of Ob/Gyn